$COST

Costco Delivers Another Strong Sales Report. Buy COST Stock Now for More Upside Ahead.

Costco reported Q3 EPS of $4.93, topping estimates by $0.01, and revenue of $70.53B, up 11.6% year over year and above estimates by $890M. Total sales rose 12% to $69.2B, comparable sales grew about 10%, and paid members were 82.9M. Analysts’ consensus is a Moderate Buy with a mean target of $1,101.25.

Original reporting
Published Jul 19, 2026, 11:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 19, 2026, 11:41 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Costco Delivers Another Strong Sales Report. Buy COST Stock Now for More Upside Ahead. — source image
Decision brief

The 30-second read

$COSTBullishMed
01

Why it matters

For traders, the actionable element is the combination of earnings/revenue beats plus improving traffic frequency and renewal rates, which can sustain momentum into the next reporting cycle.

02

Market read

Concrete quarterly beats and membership retention metrics can influence near-term positioning in COST, though the article is still largely a results recap plus promotional buy framing.

03

What to watch

The article omits margin, inventory, guidance, and any cost pressures; membership growth and renewal rates may not fully offset potential expense or competitive pressures.

Relevance 7/10Novelty 6/10Timing: post-quarter sales and earnings narrative, ahead of next earnings/guidance updates

Background

The piece summarizes Costco’s reported Q3 performance and membership renewal metrics, then discusses analyst consensus and price targets.

Company-level read

Ticker impact

$COSTBullishMedium confidence
Context

Article cites Costco’s Q3 EPS of $4.93 (beat by $0.01) and revenue $70.53B (up 11.6% YoY, beat by $890M).

Expected impact

Likely supports upward bias, but magnitude depends on how the market prices the already-reported quarter and any forward guidance not included here.

Evidence & confidence

The text provides concrete quarterly results (EPS, revenue, comparable sales, traffic, renewal rates) and analyst target/upside figures, which can reinforce momentum and sentiment.

Market effects

Reinforces the defensive, membership-driven retail model and may support read-across to other warehouse/consumer staples retailers.

No specific regional impact beyond U.S. and Canada renewal-rate disclosure.

Global renewal rate and traffic frequency metrics suggest resilience beyond North America.

Counterpoint

Upside framing relies on analyst targets and “if July sales are even better,” without new forward guidance or a fresh catalyst beyond the reported quarter.

Key entities

  • Costco Wholesale

    Subject of the article, with Q3 EPS and revenue beats plus membership renewal metrics cited.

  • Gary Millerchip

    CFO quoted for membership and renewal-rate figures.

Related articles

$PGMed

Drugmakers, retailers must face ’maximum strength’ claim in decongestant false ad litigation in US

Nasdaq sees best day in over a month as Microsoft breathes life back into AI trade By Jonathan Stempel NEW YORK, July 30 (Reuters) - A federal appeals court on Thursday revived portions of nationwide litigation in which consumers accused drugmakers such as Procter & Gamble and retailers such as CVS of selling billions of dollars of over-the-counter decongestants that didn’t work. The litigation comprised about 100 lawsuits filed after a U.S.

$CRCLMed

Here Are Monday’s Best Wall Street Analyst Research Calls: Atmos Energy, Best Buy, Biogen, Capital One, Costco, Disney, Papa John’s International, Shopify, and More

The article lists Monday analyst calls and market moves. It highlights SK hynix’s Nasdaq debut, up about 12.8% to $168.01 after raising nearly $26.5B. It cites upgrades including BIIB to Buy at $235, COF to Buy at $229, and SHOP to Buy at $160, plus downgrades like BBY to Hold. Circle (CRCL) rose ~15% on OCC approval.

$COSTMed

Slowing Costco Sales Growth Unnerves Investors

Costco shares fell 4.1% on Thursday after a June sales update showed slower growth. Net sales rose 10.6% in June, the slowest since February, versus 14% in May. The stock closed at $912.97, down from a $1,094.32 May 19 high. D.A. Davidson reiterated a $1,000 price target.

$COSTMed

Jim Cramer: 'Costco's in a funk' but still a good name in a bad neighborhood

Costco reported June sales rose 10.6% year over year to $29.4B, slightly below expectations, with U.S. comps excluding gasoline up 7.6% versus 8.7% in May. Shares fell over 4%. Analysts cited “fine” results but below lofty expectations; valuation is about 41x forward earnings. Costco membership growth also slowed, and it will release July sales Aug. 5.